Sparfloxacin INN 200mg Tablet.
Sparfloxacin is indicated for the treatment of adults with following infections caused by susceptible strains of the designated microorganisms: Community Acquired Pneumonia, Acute bacterial exacerbations of chronic bronchitis, Sinusitis, Bronchitis, Chronic Obstructive Pulmonary Disease (COPD), Lung abscess, all other RTIs. Sparonex can also be indicated in Skin and Soft Tissue Infections, Urinary Tract Infections.
Sparfloxacin INN 200mg Tablet.
Sparfloxacin is indicated for the treatment of adults with following infections caused by susceptible strains of the designated microorganisms: Community Acquired Pneumonia, Acute bacterial exacerbations of chronic bronchitis, Sinusitis, Bronchitis, Chronic Obstructive Pulmonary Disease (COPD), Lung abscess, all other RTIs. Sparonex can also be indicated in Skin and Soft Tissue Infections, Urinary Tract Infections.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.